Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
Razieh Parizad, Researcher at Tabriz University of Medical Sciences, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Exploration of Neuroprotective Therapy, adding:
“Excited to share that our systematic review, ‘Factor XI inhibitors versus direct oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review of efficacy and safety’, has been published in Exploration of Neuroprotective Therapy.
This systematic review evaluates the efficacy and safety of FXI inhibitors compared to DOACs for stroke prevention in atrial fibrillation.
Key findings include a significant reduction in major bleeding with FXI inhibitors, although DOACs were more effective in preventing stroke or systemic embolism.
I am grateful to express my sincere gratitude to Dr. Bata for his invaluable mentorship, guidance, and support throughout this work.
I am also grateful to my co-authors for their collaboration and contributions.”
Title: Factor XI inhibitors versus direct oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review of efficacy and safety
Authors: Razieh Parizad, Juniali Hatwal, Haleh Bodagh, Akash Batta, Bishav Mohan
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 7, 2026, 15:54Hassan Raza: Beyond the 100 Minus Age Rule in Bone Marrow Cellularity
-
Nov 7, 2026, 15:42Andrew Zapfel։ Advancing Sickle Cell Disease Care Through Training, Advocacy and Collaboration
-
Nov 7, 2026, 15:34Salih Ehsan: Iron Deficiency Beyond Conventional Ferritin Cutoffs
-
Nov 7, 2026, 15:21Shamee Shastry: Improving the Reliability and Reproducibility of the Monocyte Monolayer Assay
-
Nov 7, 2026, 14:39AI-Assisted Donor Screening and Transfusion Decision Support: A Prospective Multicentre Evaluation
-
Nov 7, 2026, 14:26Qiong Tang: Changing Perspectives on Iron Deficiency and Supplementation
-
Nov 7, 2026, 14:21Nathan Connell: Bringing VWD Education Across Borders to Improve Patient Care
-
Nov 7, 2026, 14:02David McIntosh: Thalassaemia Care Needs More Than Breakthrough Therapies
-
Nov 7, 2026, 14:00Farzin Beygui: SOLOTAVI Tests Aspirin Discontinuation After TAVI